Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

952
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
952
Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

461
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
461

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Estimates of Incidence and Prevalence of Conversions to Mild Cognitive Impairment and Dementia in Patients With Essential Tremor.

Neurology·2026
Same author

The Role of Apathy in the Association Between Depressive Symptoms and Subjective Cognitive Complaints.

International journal of geriatric psychiatry·2026
Same author

Valacyclovir Treatment in Mild Cognitive Impairment: The VALMCI Randomized Clinical Trial.

Alzheimer disease and associated disorders·2026
Same author

Cueing to facilitate naming in MAPT-associated behavioral variant frontotemporal dementia: a preliminary report.

Archives of clinical neuropsychology : the official journal of the National Academy of Neuropsychologists·2026
Same author

Factors influencing accelerated progression in behavioral variant frontotemporal dementia.

Journal of neurology·2026
Same author

Objective Assessment of Financial Decision-Making With a Simulated Online Money Management Task in Older Adults: Protocol for a Prospective Observational Study.

JMIR research protocols·2026

Related Experiment Video

Updated: Nov 4, 2025

The 4 Mountains Test: A Short Test of Spatial Memory with High Sensitivity for the Diagnosis of Pre-dementia Alzheimer's Disease
06:23

The 4 Mountains Test: A Short Test of Spatial Memory with High Sensitivity for the Diagnosis of Pre-dementia Alzheimer's Disease

Published on: October 13, 2016

33.0K

Baseline Infection Burden and Cognitive Function in Elders with Essential Tremor.

Daniella Iglesias-Hernandez1, Silvia Chapman2,3, Keith Radler1

  • 1Department of Neurology, University of Texas Southwestern Medical Center, Dallas, Texas, US.

Tremor and Other Hyperkinetic Movements (New York, N.Y.)
|May 24, 2021
PubMed
Summary

Infection exposure did not impact baseline cognition in essential tremor (ET) patients. Moderate infections correlated with better attention over time, while rubella history predicted faster visuospatial decline.

Keywords:
clinicalepidemiologyessential tremorinfection burdenrisk factorsself-reported questionnaires

More Related Videos

Traditional Trail Making Test Modified into Brand-new Assessment Tools: Digital and Walking Trail Making Test
08:07

Traditional Trail Making Test Modified into Brand-new Assessment Tools: Digital and Walking Trail Making Test

Published on: November 23, 2019

11.4K
Highlighting and Reducing the Impact of Negative Aging Stereotypes During Older Adults' Cognitive Testing
06:58

Highlighting and Reducing the Impact of Negative Aging Stereotypes During Older Adults' Cognitive Testing

Published on: January 24, 2020

7.5K

Related Experiment Videos

Last Updated: Nov 4, 2025

The 4 Mountains Test: A Short Test of Spatial Memory with High Sensitivity for the Diagnosis of Pre-dementia Alzheimer's Disease
06:23

The 4 Mountains Test: A Short Test of Spatial Memory with High Sensitivity for the Diagnosis of Pre-dementia Alzheimer's Disease

Published on: October 13, 2016

33.0K
Traditional Trail Making Test Modified into Brand-new Assessment Tools: Digital and Walking Trail Making Test
08:07

Traditional Trail Making Test Modified into Brand-new Assessment Tools: Digital and Walking Trail Making Test

Published on: November 23, 2019

11.4K
Highlighting and Reducing the Impact of Negative Aging Stereotypes During Older Adults' Cognitive Testing
06:58

Highlighting and Reducing the Impact of Negative Aging Stereotypes During Older Adults' Cognitive Testing

Published on: January 24, 2020

7.5K

Area of Science:

  • Neurology
  • Infectious Disease Epidemiology
  • Cognitive Science

Background:

  • Essential tremor (ET) patients face higher risks of cognitive impairment.
  • Infectious agent exposure is a potential, yet unexamined, predictor of cognitive decline in ET.
  • Previous research links infection burden to cognitive performance in Alzheimer's and Parkinson's disease.

Purpose of the Study:

  • To investigate the association between baseline infection burden and cognitive performance in ET patients.
  • To determine if infection burden predicts cognitive decline over time in essential tremor.

Main Methods:

  • 160 non-demented elderly ET participants completed cognitive evaluations at three time points.
  • A validated infection burden questionnaire (t-IBQ) assessed past infectious agent exposures and episode frequency.
  • Statistical analyses included analysis of covariance and generalized estimating equations (GEEs).

Main Results:

  • No significant association was found between overall infection burden and baseline cognitive performance.
  • A significant time interaction indicated that moderate infection burden at baseline was linked to improved attention performance over time (p=0.013).
  • A history of rubella infection was associated with a faster decline in visuospatial performance (p=0.046).

Conclusions:

  • Findings on infection burden and cognitive performance in ET are mixed.
  • Moderate infection burden may be associated with better attention trajectories.
  • Rubella infection history appears linked to visuospatial decline in this ET cohort, warranting further investigation.